NOVTUNovanta Inc.
62.05USD-10.18%Mkt Cap: P/E:

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internatio…

Key Statistics

Company
Market Cap
Enterprise Value1.91B $
Revenue (TTM)1.03B $
Gross Profit435.28M $
Net Income (TTM)53.83M $
Revenue/Share26.45 USD
Last Price62.05 USD
Fiscal Year EndDec 2025
MR QuarterJul 2026
Employees3.0K
CountryUS
SectorTechnology
IndustryScientific & Technical Instruments
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA10.57
EV/Revenue1.86
P/S
P/B1.45
EPS (TTM)
EPS (Forward)
52W Range
47.5752% of range75.59
52W High75.59 USD
52W Low47.57 USD
Profitability
Gross Margin44.39%
Oper. Margin11.50%
EBITDA Margin17.57%
Profit Margin5.49%
ROE4.10%
ROA2.98%
Growth
Revenue Growth10.30%
Earnings Growth150.00%
Cash Flow & Leverage
Operating CF64.06M $
CapEx (TTM)15.63M $
FCF Margin11.50%
FCF Yield
Net Debt-433.05M $
Net Debt/EBITDA-2.39
Balance Sheet
Debt/Equity0.23
Current Ratio4.57
Quick Ratio3.65
Book Value/Sh42.74 USD
Cash/Share19.00 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio
Ex-Div Date
Pay DateAug 3, 2026
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.
Float37.54M
Insiders0.00%
Institutions253.04%
Short Interest
Short Ratio2.9d
Shares Short57.93K
Short (prev mo.)68.62K
Technical
SMA 5065.03 (-4.6%)
SMA 20059.74 (+3.9%)
Beta1.68
S&P 52W Chg18.16%
Avg Vol (30d)17.30K
Avg Vol (10d)23.37K
Technical Indicators
RSI (14)43.0
MACD0.9221
MACD Signal0.5666
MACD Hist.+0.3555
BB Upper71.49 USD
BB Middle64.04 USD
BB Lower56.59 USD
BB Width23.26%
ATR (14)3.209 USD
Vol Ratio (20d)2.45x